Vcanbio Cell & Gene Engineering Corp Ltd (600645) — Capital Reinvestment Ratio
Vcanbio Cell & Gene Engineering Corp Ltd (600645) has a Capital Reinvestment Ratio of 0.13x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥103.70 Million) in capital expenditures (CN¥13.28 Million). See Vcanbio Cell & Gene Engineering Corp Ltd (600645) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Vcanbio Cell & Gene Engineering Corp Ltd Capital Reinvestment Ratio (1999–2025)
This chart tracks Vcanbio Cell & Gene Engineering Corp Ltd's Capital Reinvestment Ratio across 25 annual periods.
Annual Capital Reinvestment Ratio for Vcanbio Cell & Gene Engineering Corp Ltd (1999–2025)
Year-by-year Capital Reinvestment Ratio for Vcanbio Cell & Gene Engineering Corp Ltd from 1999 to 2025. For live market cap and broader valuation context, see Vcanbio Cell & Gene Engineering Corp Ltd market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | CN¥313.63 Million | CN¥49.56 Million | ▼ -33.1% |
| 2024 | 0.24x | CN¥285.19 Million | CN¥67.32 Million | ▼ -20.3% |
| 2023 | 0.30x | CN¥299.02 Million | CN¥88.61 Million | ▼ -21.8% |
| 2022 | 0.38x | CN¥261.89 Million | CN¥99.19 Million | ▼ -4.8% |
| 2021 | 0.40x | CN¥320.96 Million | CN¥127.74 Million | ▲ +6.0% |
| 2020 | 0.38x | CN¥244.35 Million | CN¥91.72 Million | ▼ -26.3% |
| 2019 | 0.51x | CN¥241.49 Million | CN¥122.95 Million | ▼ -48.3% |
| 2018 | 0.99x | CN¥130.08 Million | CN¥128.13 Million | ▼ -16.6% |
| 2017 | 1.18x | CN¥70.27 Million | CN¥83.02 Million | ▼ -37.1% |
| 2016 | 1.88x | CN¥143.67 Million | CN¥269.85 Million | ▼ -88.1% |
| 2015 | 15.74x | CN¥8.17 Million | CN¥128.70 Million | ▲ +5665.4% |
| 2014 | 0.27x | CN¥221.45 Million | CN¥60.47 Million | ▼ -57.1% |
| 2013 | 0.64x | CN¥110.72 Million | CN¥70.43 Million | ▼ -19.4% |
| 2012 | 0.79x | CN¥70.41 Million | CN¥55.56 Million | ▲ +488.4% |
| 2011 | 0.13x | CN¥110.44 Million | CN¥14.81 Million | ▲ +352.1% |
| 2010 | 0.03x | CN¥175.93 Million | CN¥5.22 Million | ▼ -78.6% |
| 2009 | 0.14x | CN¥124.92 Million | CN¥17.32 Million | ▼ -17.0% |
| 2008 | 0.17x | CN¥121.60 Million | CN¥20.32 Million | ▲ +4.1% |
| 2007 | 0.16x | CN¥111.68 Million | CN¥17.92 Million | ▼ -74.4% |
| 2006 | 0.63x | CN¥76.12 Million | CN¥47.67 Million | ▼ -7.8% |
| 2005 | 0.68x | CN¥84.69 Million | CN¥57.55 Million | ▲ +44.2% |
| 2004 | 0.47x | CN¥57.76 Million | CN¥27.23 Million | ▼ -45.5% |
| 2003 | 0.86x | CN¥41.74 Million | CN¥36.08 Million | ▲ +219.3% |
| 2000 | 0.27x | CN¥31.71 Million | CN¥8.58 Million | ▼ -87.2% |
| 1999 | 2.12x | CN¥4.13 Million | CN¥8.76 Million | — |